phase 3 trial

Watch | ‘Mistake to Authorise Covaxin Without Phase 3 Data’: Dr Ashish Jha

Serum Institute Gets DCGI Nod to Resume Clinical Trial of Oxford COVID-19 Vaccine

Serum Institute Pauses Trials of AstraZeneca’s Potential COVID-19 Vaccine in India

COVID-19: AstraZeneca Halts Oxford Vaccine Trial After a Report of Adverse Effects